OPKO Health, Inc. Interest and Other Income
OPKO Health, Inc. (OPK) reported Interest and Other Income of $16.93 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2013-08-09
- OPKO Health, Inc. interest and other income for the quarter ending 2013-06-30 was $16.93M.
- OPKO Health, Inc. interest and other income for the quarter ending 2013-03-31 was -$24.06M, a 2569.82% decline year-over-year.
- OPKO Health, Inc. interest and other income for the quarter ending 2012-06-30 was -$427.00K.
- OPKO Health, Inc. interest and other income for the quarter ending 2012-03-31 was $974.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month |
|---|---|---|
| 2013-06-30 | $16.93M 10-Q · filed 2013-08-09 | -$7.13M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$24.06M 10-Q · filed 2013-05-10 | |
| 2012-06-30 | -$427.00K 10-Q · filed 2013-08-09 | $547.00K 10-Q · filed 2013-08-09 |
| 2012-03-31 | $974.00K 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |